Background. Cognitive impairment is a common complaint among cancer survivors, significantly impacting working memory, attention, executive function, and information processing speed. This meta-analysis aims to evaluate the effect of neuropsychological interventions on the cognitive function of non-central nervous system (non-CNS) cancer survivors.Methods. Three databases (PubMed, PsycInfo, and CAJ Full-text Database) were searched from January 2010 to September 2015. Controlled clinical trials of neuropsychological interventions for the treatment of cognitive impairment in cancer survivors were considered for inclusion.Results. A total of 10 eligible trials were included in this meta-analysis. Three trials assessed the effects of cognitive...
Item does not contain fulltextCONTEXT: After successful cancer treatment, a substantial number of su...
Cognitive impairment is one of the most common neurological disorders in neuro-oncological patients ...
PURPOSE: To assess cognitive functioning in occupationally active non-central nervous system cancer ...
Purpose: Evidence is mixed regarding long-term cognitive deficits in patients treated with chemother...
Objective: Chemotherapy-induced cognitive impairments are reported by many cancer survivors. Researc...
OBJECTIVE: Chemotherapy-induced cognitive impairments are reported by many cancer survivors. Researc...
This research aimed to address the gap in evidence-based treatment available for cancer survivors wh...
Purpose: Cognitive impairment is reported frequently by cancer survivors. There are no proven treatm...
ObjectiveThe aim of this meta-analysis was to assess whether chemotherapy-related cognitive impairme...
Chemotherapy-induced cognitive impairment, also known as “chemo brain”, is a detrimental side effect...
International audienceBACKGROUND:Advances in diagnostic and therapeutic strategies in oncology have ...
The potentially detrimental effects of cancer and related treatments on cognitive functioning are em...
R. Laush1, T. Burnham1, K. Roemer1, R. Galindo1, K. Kemble2,3 1Central Washington University, Ellens...
Background: Cognitive impairment is a distressing, disruptive, and potentially debilitating symptom ...
Context. After successful cancer treatment, a substantial number of survivors continue to experience...
Item does not contain fulltextCONTEXT: After successful cancer treatment, a substantial number of su...
Cognitive impairment is one of the most common neurological disorders in neuro-oncological patients ...
PURPOSE: To assess cognitive functioning in occupationally active non-central nervous system cancer ...
Purpose: Evidence is mixed regarding long-term cognitive deficits in patients treated with chemother...
Objective: Chemotherapy-induced cognitive impairments are reported by many cancer survivors. Researc...
OBJECTIVE: Chemotherapy-induced cognitive impairments are reported by many cancer survivors. Researc...
This research aimed to address the gap in evidence-based treatment available for cancer survivors wh...
Purpose: Cognitive impairment is reported frequently by cancer survivors. There are no proven treatm...
ObjectiveThe aim of this meta-analysis was to assess whether chemotherapy-related cognitive impairme...
Chemotherapy-induced cognitive impairment, also known as “chemo brain”, is a detrimental side effect...
International audienceBACKGROUND:Advances in diagnostic and therapeutic strategies in oncology have ...
The potentially detrimental effects of cancer and related treatments on cognitive functioning are em...
R. Laush1, T. Burnham1, K. Roemer1, R. Galindo1, K. Kemble2,3 1Central Washington University, Ellens...
Background: Cognitive impairment is a distressing, disruptive, and potentially debilitating symptom ...
Context. After successful cancer treatment, a substantial number of survivors continue to experience...
Item does not contain fulltextCONTEXT: After successful cancer treatment, a substantial number of su...
Cognitive impairment is one of the most common neurological disorders in neuro-oncological patients ...
PURPOSE: To assess cognitive functioning in occupationally active non-central nervous system cancer ...